ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,651.90
0.23%
Dow Jones
41,488.19
0.00%
Gold vs US Dollar
2,993.48
0.08%
Brent Oil
71.175
0.58%
Bitcoin
83,087.13
0.65%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Jasper Therapeutics Inc (JSPRW)

  7. Jasper Therapeutics Inc (JSPRW) News

Jasper Therapeutics (JSPRW)

Jasper Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JSPRW
DateTimeSourceHeadlineSymbolCompany
28/02/202514:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:JSPRWJasper Therapeutics Inc
27/02/202513:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
18/02/202522:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
18/02/202522:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
11/02/202521:00Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:JSPRWJasper Therapeutics Inc
08/01/202512:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
13/12/202401:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
13/12/202401:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
14/11/202423:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:JSPRWJasper Therapeutics Inc
14/11/202420:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:JSPRWJasper Therapeutics Inc
07/11/202412:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
07/11/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JSPRWJasper Therapeutics Inc
15/10/202410:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
12/09/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
12/09/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
20/06/202410:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
13/06/202401:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
13/06/202401:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
12/06/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRWJasper Therapeutics Inc
10/06/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
10/06/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
10/06/202422:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
10/06/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
10/06/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRWJasper Therapeutics Inc
07/06/202421:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:JSPRWJasper Therapeutics Inc
07/06/202421:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:JSPRWJasper Therapeutics Inc
07/06/202421:01Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:JSPRWJasper Therapeutics Inc
07/06/202420:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JSPRWJasper Therapeutics Inc
14/05/202417:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JSPRWJasper Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:JSPRW

Your Recent History

TG
RL9A
VK
TG
LYP6
Amundi Stoxx Europe 600 ...
NASDAQ
NNE
Nano Nuclear Energy
TG
BE26
Invesco BulletShares 202...
TG
BSE7
Invesco Markets II
TG
LYPD
Amundi MSCI World Financ...
CSE
GET
GameOn Entertainment Tec...
CSE
VTI
Valdor Technology
TSXV
VUL
Vulcan Minerals
TG
ASGA
Assicurazioni Generali
TSXV
IGX.DB
Intelgenx Technologies
TG
HIJ2
Arcadis NV
COIN
MOLKUSD
MobilinkToken
NASDAQ
JCTC
Jewett Cameron Trading
TG
GEQB
Invesco Capital Management
NYSE
OEC
Orion
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads